about
Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-2Hsc70 contributes to cancer cell survival by preventing Rab1A degradation under stress conditionsPercutaneous carbon dioxide treatment using a gas mist generator enhances the collateral blood flow in the ischemic hindlimb.Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells.Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells.Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line.Lipid synthesis is promoted by hypoxic adipocyte-derived exosomes in 3T3-L1 cells.Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules.Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions.Myeloid HIF-1 attenuates the progression of renal fibrosis in murine obstructive nephropathy.HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liverGeneration of a rat monoclonal antibody specific for heat shock cognate protein 70Generation of a rat monoclonal antibody specific for hsp72Identification of low-abundance proteins in serum via the isolation of HSP72 complexesA dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction
P50
Q34116922-516929CD-4A6E-40DF-B357-C99D46C3AE17Q35163915-C1AE4892-6A1F-4C8F-AAAD-26F30EDCAD37Q35226848-521F353F-5DC4-440D-AB67-09E7285C1E41Q38697766-445E48E1-3FE7-498D-BD41-3D24FD76B36EQ38772328-30E47657-197E-46FD-BB5D-3B333AF7940AQ39078372-AB86F2B4-ABDB-415E-A192-F0324399CBB7Q42806958-051EC459-A0BA-48D5-BE72-B6F01FA21634Q49905566-405ED0FD-F690-4A36-99CE-ECAFCB84CFC3Q51306687-E46C82DE-5C8C-48F3-A0B0-EA3C64041A75Q52963122-672DA636-C807-42A6-B9D0-D030071C716FQ58705468-0954CACF-19FA-477B-8DE5-9254DF1395EAQ82306919-E390D891-9985-4817-86D0-ED480F9A1B81Q84787238-2CEA48F4-38D1-4D24-BA3F-D2EDC99024CFQ87104041-A56FAF00-38CC-4772-B317-73FDBDF0D5D2Q91028355-567F7A19-1D2B-4146-9315-56A1A57359D6Q95611011-A4BA49D7-7842-4FA3-8918-4B9F87A6BC98
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Masako Tanaka
@en
Masako Tanaka
@nl
type
label
Masako Tanaka
@en
Masako Tanaka
@nl
prefLabel
Masako Tanaka
@en
Masako Tanaka
@nl
P31
P496
0000-0002-4484-1712